9 participants
The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-05-17
- Start Date:
- 2024-05-27
- Completion:
- 2027-05-27
Conditions
- Systemic Lupus Erythematosus (SLE)
- Sjogren's Syndrome
- Systemic Sclerosis
- Inflammatory Myopathy
- ANCA Associated Vasculitis
- Antiphospholipid Syndrome
Interventions
- BIOLOGICAL
No Results Yet